Brief: Lucira Health Announces FDA Authorization Of Combination Covid-19 & Flu Test At Point-Of-Care
22/11/2022 21:02
Nov 22 (Reuters) - Lucira Health Inc LHDX.O :
* LUCIRA HEALTH ANNOUNCES FDA AUTHORIZATION OF COMBINATION
COVID-19 & FLU TEST AT POINT-OF-CARE
* LUCIRA HEALTH INC - POSITIVE RESULT AS QUICKLY AS 11
MINUTES,
NEGATIVE RESULT IN 30 MINUTES, ALLOWING DIAGNOSIS DURING PATIENT
VISIT
Source text for Eikon: ID:nGNX4TmzSN
Further company coverage: LHDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lucira Health
See all newsBrief: Lucira Health Inc Filed Its Amended Chapter 11 Plan Of Liquidation With Bankruptcy Court
Brief: Lucira Health Files Proposed Chapter 11 Plan Of Liquidation
Brief: Bankruptcy Court Approves Lucira Health Assets Sale To Pfizer
Brief: Lucira Health Inc Says On April 6, 2023 Co Held Auction Relating To Disposition Of All Or Substantially All Of Company's Assets
Brief: Lucira Health Announces U.S. Launch Of First & Only At-Home Combination Covid-19 & Flu Test Amidst Sale Process